Abstract
Gastric cancer is the second leading cause of cancer deaths worldwide, and more understanding of its molecular basis is urgently needed. Gastric gland mucin secreted from pyloric gland cells, mucous neck cells, and cardiac gland cells of the gastric mucosa harbors unique O-glycans carrying terminal alpha 1,4-linked N-acetylglucosamine (alpha GlcNAc) residues. We previously reported that alpha GlcNAc loss correlated positively with poor outcomes for patients with differentiated-type gastric cancer. However, the molecular mechanisms underlying these outcomes remained poorly understood. Here, we examined the effects of upregulated alpha GlcNAc expression on malignant phenotypes of the differentiated-type gastric cancer cell lines, AGS and MKN7. Upregulation of alpha GlcNAc following ectopic expression of its biosynthetic enzyme attenuated cell proliferation, motility, and invasiveness of AGS and MKN7 cells in vitro. Moreover, AGS cell tumorigenicity was significantly suppressed by alpha GlcNAc overexpression in a xenograft model. To define the molecular mechanisms underlying these phenotypes, we investigated alpha GlcNAc binding proteins in AGS cells and identified Mucin-1 (MUC1) and podocalyxin. Both proteins were colocalized with alpha GlcNAc on human gastric cancer cells. We also found that alpha GlcNAc was bound to MUC1 in murine normal gastric mucosa. When we assessed the effects of alpha GlcNAc binding to MUC1, we found that alpha GlcNAc blocked galectin-3 binding to MUC1, phosphorylation of the MUC1 C-terminus, and recruitment of Src and beta-catenin to that C-terminus. These results suggest that alpha GlcNAc regulates cancer cell phenotypes by dampening MUC1 signal transduction.
Funding Information
  • Japan Society for the Promotion of Science (18K08613, 19H03441)

This publication has 34 references indexed in Scilit: